Rainy
I have been reading papers for hours on clemastine.
In support of the initial reference.
Systematic Analysis of Clemastine, a Candidate Apicomplexan
Parasite-Selective Tubulin-Targeting Agent
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744746/pdf/ijms-23-00068.pdf
"Abstract: Apicomplexan parasites, such as Toxoplasma gondii, Plasmodium spp., Babesia spp., and Cryptosporidium spp., cause significant morbidity and mortality. Existing treatments are problematic due
to toxicity and the emergence of drug-resistant parasites. Because protozoan tubulin can be selectively
disrupted by small molecules to inhibit parasite growth, we assembled an in vitro testing cascade
to fully delineate effects of candidate tubulin-targeting drugs on Toxoplasma gondii and vertebrate
host cells. Using this analysis, we evaluated clemastine, an antihistamine that has been previously
shown to inhibit Plasmodium growth by competitively binding to the CCT/TRiC tubulin chaperone
as a proof-of-concept."
Edit to note.
We have access to another potent microtubule disrupter in fenbendazole.
I wonder if there may be synergy.
Post Edited (carlnpa) : 10/26/2023 3:35:16 PM (GMT-8)